Categories: News

Ashley Parish Joins CenExel as Chief Sales Officer

SALT LAKE CITY, UT / ACCESSWIRE / January 16, 2024 / CenExel proudly announces the appointment of Ashley Parish as their new Chief Sales Officer, further fortifying its commitment to innovation and growth. With a career spanning over 25 years in the life sciences industry, Ashley brings a wealth of knowledge and experience to this pivotal role.

As the Chief Sales Officer, Ashley will be instrumental in aligning CenExel’s corporate mission with strategic sales activities. Her focus will extend to fostering impactful relationships and steering rapid growth across CenExel’s diverse sites. Additionally, Ashley will provide dynamic leadership to the sales team, emphasizing the delivery of outstanding customer service.

Stuart Goldblatt, Chief Executive Officer of CenExel, conveyed his enthusiasm regarding Ashley’s appointment, stating, “We are excited to welcome Ashley to CenExel as our Chief Sales Officer. Her exceptional track record and accomplishments in life sciences make her a valuable asset to our leadership team. Ashley’s vision and dedication to excellence align seamlessly with our goals for ongoing success and development.”

Ashley joins CenExel from Teckro, where she served as the Senior Vice President of Strategic Alliances. Prior to that, she held various roles at IQVIA, the world’s largest provider of advanced analytics, technology solutions, and clinical research services, contributing significantly to global enterprise business development efforts. Ashley also served as business development partner at Covance (Fortrea), Cognizant and ICON.

Expressing her excitement about joining CenExel, Ashley remarked, “I am honored to be part of CenExel, a company renowned for its commitment to advancing clinical research and delivering exceptional solutions. I look forward to contributing to the continued achievements and progress of this fantastic organization.”

CenExel anticipates that Ashley’s leadership will further enhance its position as a frontrunner in the evolving landscape of clinical research.

Contact Information

Sara Koeblin
Director of Corporate Communications
s.koeblin@cenexel.com
(617) 639-6075

Related Images

SOURCE: CenExel

View the original press release on newswire.com.

Staff

Recent Posts

Daily Fit Notes Rolls Out Affordable Fitness Solutions for the Modern Lifestyle

Daily Fit Notes, founded by Justin Brey in New York, launches a text-based subscription fitness…

2 days ago

WillowWood Rebrand by DD.NYC Wins Gold Anthem Award for Product and Innovation in 2024 Rebrand

MT. STERLING, Ohio, Dec. 20, 2024 /PRNewswire/ -- WillowWood, a global leader in prosthetic solutions,…

2 days ago

Quantum Biopharma Announces Closing of Second Tranche

TORONTO, ON / ACCESSWIRE / December 20, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma"…

2 days ago

Glow Lifetech Announces Completion of Final Payment under Swiss Pharma Share Exchange Agreement and Debt Settlement

Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Glow Lifetech Corp. (CSE: GLOW) (OTC Pink:…

2 days ago